Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Early clinical experience with a new trifocal intraocular lens

Poster Details

First Author: B.Toygar TURKEY

Co Author(s):    O. Yabas Kiziloglu   A. Hacimustafaoglu   O. Toygar              

Abstract Details

Purpose:

To evaluate the refractive and visual outcomes after implantation of a trifocal intraocular lens (IOL).

Setting:

Bahcesehir University Faculty of Medicine, Göztepe Medical Park Hospital,Turkey.

Methods:

A case series of 11 patients implanted bilaterally with a trifocal IOL (FineVision; PhysIOL, Liege, Belgium). Visual outcomes that were assessed postoperatively included uncorrected and corrected distance, intermediate, and near visual acuity. Postoperative contrast sensitivity was also evaluated.

Results:

22 eyes of 11 patients with a mean age of 59.18 ± 7.71 years were analyzed. Patient follow-up ranged from 1 to 12 months after surgery. Preoperative corrected distance visual acuity (CDVA) was 0.33 ± 0.18 logMAR. At the final follow-up visit, CDVA was 0.00 ± 0.02 logMAR, uncorrected distance visual acuity was 0.08 ± 0.01 logMAR, uncorrected intermediate visual acuity was -0.02 ± 0.09 logMAR, and uncorrected near visual acuity was 0.00 ± 0.02 logMAR. Postoperative mean residual sphere was 0.06 ± 0.22 diopters (D), with a mean residual cylinder of -0.28 ± 0.30D. Postoperative mean spherical equivalent was -0.09 ± 0.21D. Postoperative low contrast visual acuity was 0.24 ± 0.08 logMAR.

Conclusions:

Early experience with trifocal FineVision IOL implanted binocularly showed good visual outcomes at all distances, especially at intermediate and near vision. Low contrast visual acuity was also satisfactory.

Financial Disclosure:

One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing